ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 157 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $324,000 | -16.7% | 6,300 | 0.0% | 0.08% | +20.6% |
| Q4 2019 | $389,000 | -8.0% | 6,300 | -10.6% | 0.06% | -10.0% |
| Q3 2019 | $423,000 | -48.2% | 7,044 | -27.1% | 0.07% | -44.4% |
| Q2 2019 | $816,000 | -19.7% | 9,667 | -9.1% | 0.13% | -20.3% |
| Q1 2019 | $1,016,000 | -51.5% | 10,637 | -64.1% | 0.16% | -55.6% |
| Q4 2018 | $2,096,000 | -7.1% | 29,594 | +12.1% | 0.36% | +21.9% |
| Q3 2018 | $2,256,000 | +3.1% | 26,393 | +39.8% | 0.29% | -4.3% |
| Q2 2018 | $2,188,000 | +180.2% | 18,879 | +95.6% | 0.30% | +158.5% |
| Q1 2018 | $781,000 | -46.6% | 9,652 | -66.4% | 0.12% | +61.6% |
| Q4 2014 | $1,462,000 | – | 28,759 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |